Tvardi Therapeutics (TVRD) Treasury Shares (2013 - 2025)
Tvardi Therapeutics (TVRD) posted Treasury Shares of $25846.0 for Q1 2025, down 99.35% sequentially from $4.0 million in Q4 2024, and up 271.78% YoY from $6952.0 in Q1 2024.
Tvardi Therapeutics (TVRD) Treasury Shares (2013 - 2025) Analysis & Trends
Tvardi Therapeutics has reported Treasury Shares for 8 years, with the latest figure at $25846.0 in Q1 2025.
- Quarterly Treasury Shares rose 271.78% year-over-year to $25846.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $25846.0 (up 271.78% YoY) and the FY2024 annual result came in at $4.0 million, up 8299.18% from the prior year.
- Treasury Shares fell to $25846.0 in Q1 2025 per TVRD's latest filing, from $4.0 million in the prior quarter.
- Over five years, Treasury Shares peaked at $4.0 million in Q4 2024 and troughed at $6952.0 in Q1 2024.
- A 5-year average of $709474.1 and a median of $640950.0 in 2022 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 8299.18% in 2024, down 99.0% in 2024.
- Over 5 years, Treasury Shares stood at $576544.0 in 2021, then plunged by 94.62% to $31043.0 in 2022, then jumped by 52.03% to $47194.0 in 2023, then surged by 8299.18% to $4.0 million in 2024, then plunged by 99.35% to $25846.0 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $25846.0, $4.0 million, and $967924.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Tvardi Therapeutics | 17.36 Mn | 17.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 25,846.00 |
| Mar 31, 2025 | 25,846.00 |
| Dec 31, 2024 | 3.96 Mn |
| Dec 31, 2024 | 3.96 Mn |
| Sep 30, 2024 | 967,924.00 |
| Sep 30, 2024 | 967,924.00 |
| Jun 30, 2024 | 976,799.00 |
| Jun 30, 2024 | 976,799.00 |
| Mar 31, 2024 | 6,952.00 |
| Mar 31, 2024 | 6,952.00 |
| Dec 31, 2023 | 47,194.00 |
| Dec 31, 2023 | 47,194.00 |
| Sep 30, 2023 | 775,711.00 |
| Sep 30, 2023 | 775,711.00 |
| Jun 30, 2023 | 791,853.00 |
| Jun 30, 2023 | 791,853.00 |
| Mar 31, 2023 | 695,720.00 |
| Mar 31, 2023 | 695,720.00 |
| Dec 31, 2022 | 31,043.00 |
| Dec 31, 2022 | 31,043.00 |